Outlook Therapeutics Inc (NASDAQ:OTLK)

Delayed Data
As of 3:59pm ET
 -0.0166 / -3.75%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Outlook Therapeutics Inc have a median target of 1.75, with a high estimate of 10.00 and a low estimate of 1.00. The median estimate represents a +311.18% increase from the last price of 0.43.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Outlook Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Dec 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 26.56%
Growthannually 29.44%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.